Tilray Brands, Inc. (TLRY)
Here's Why Tilray Brands, Inc. (TLRY) Fell More Than Broader Market
In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $0.5, indicating a -6.55% shift from the previous trading day.
Tilray Brands, Inc. (TLRY) Stock Declines While Market Improves: Some Information for Investors
Tilray Brands, Inc. (TLRY) reached $0.4 at the closing of the latest trading day, reflecting a -2.84% change compared to its last close.
Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today
Tilray Brands, Inc. (TLRY) closed at $0.38 in the latest trading session, marking a -9.07% move from the prior day.
Why Tilray Stock Plummeted by 26% in April
The marijuana sector, beset by a host of tough challenges, has been out of favor with investors for years. That looks unlikely to change as long as the drug remains illegal at the federal level, and even that might not save some of the market's players.
Tilray Brands Could Bounce Big
Tilray Brands missed Q3 expectations but improved its balance sheet, with net debt at $14 million. Despite revenue and EBITDA misses, Tilray's valuation is attractive, trading at 6.85X projected FY27 adjusted EBITDA, suggesting potential gains of up to 77%. Risks include NASDAQ delisting and integration challenges from numerous acquisitions, but maintaining the NASDAQ listing is crucial.
Tilray: Q3 Earnings Could Be The Inflection Point It Needs
Tilray's Q3 earnings show promising signs of improving fundamentals with expanding margins and effective cost management, combined with a clean balance sheet. Management's strategy shift to prioritizing profitable growth offers a viable path to long-term profitability. Despite improving fundamentals, Tilray appears to be undervalued, in my opinion.
Tilray Brands, Inc. (TLRY) Q3 2025 Earnings Call Transcript
Tilray Brands, Inc. (NASDAQ:TLRY ) Q3 2025 Earnings Conference Call April 8, 2025 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs & Communications Officer Irwin Simon - Chairman & Chief Executive Officer Ty Gilmore - President, Tilray Beverages North America Carl Merton - Chief Financial Officer Denise Faltischek - Chief Strategy Officer & Head, International Jared Simon - President, Manitoba Harvest & Tilray Wellness at Manitoba Harvest Hemp Foods. Conference Call Participants Aaron Grey - Alliance Global Partners Victor Ma - TD Securities Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Matt Bottomley - Canaccord Genuity Michael Lavery - Piper Sandler Operator Thank you for joining today's conference call to discuss Tilray Brands Financial Results for the fiscal 2025 third quarter ended February 28, 2025.
Tilray shares sink after quarterly revenue falls short of estimates
Tilray Inc (NASDAQ:TLRY) shares plunged more than 16% after the cannabis and consumer packaged goods-producer's fiscal third quarter financial report disappointed investors. Revenue fell year-over-year to $185.8 million from $188.3 million, well below expectations of $209.8 million.
Compared to Estimates, Tilray Brands (TLRY) Q3 Earnings: A Look at Key Metrics
The headline numbers for Tilray Brands (TLRY) give insight into how the company performed in the quarter ended February 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tilray Brands, Inc. (TLRY) Reports Q3 Loss, Lags Revenue Estimates
Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to break-even earnings per share a year ago.
Is Tilray Brands a Millionaire Maker?
Tilray Brands (TLRY -4.48%) went public in the U.S. in 2018 when cannabis was among Wall Street's hottest topics. However, despite the cannabis market surpassing $38 billion last year in the U.S. alone, Tilray has been a colossal disappointment.
Tilray's Stock Is as Cheap as It's Been Since 2020. 1 Thing to Know Before You Buy.
Many valuation metrics suggest that Tilray Brands (TLRY -0.70%) is a screaming buy right now. Just look at the cannabis stock's price-to-sales ratio.
